Company i earning alot compare to previous quartery report
Just impairment lost make the report not looking good

Now whole market lack of carton paper, see what is muda holding price now

Right issue on friday

AnnouDGB - RENOUNCEABLE RIGHTS ISSUE OF 956,377,178 NEW ORDINARY SHARES IN DGB ("DGB SHARES") ("RIGHTS SHARES") TOGETHER WITH 478,188,586 FREE DETACHABLE WARRANTS IN DGB ("WARRANTS C") ON THE BASIS OF 6 RIGHTS SHARES TOGETHER WITH 3 FREE WARRANTS C FOR EVERY 1 EXISTING DGB SHARE HELD BY THE ENTITLED SHAREHOLDERS OF THE COMPANY ("RIGHTS ISSUE WITH WARRANTS")
DGB ASIA BERHAD

Paper Factory ! Supply 6 listed companies on hand! Supply karex accounted for 21%! And other customers!

now its fair price to buy before fly don't wait till rm0.50

Buckle up ready to fly

Cheap price to buy before its fly
Target Price 0.15
Target Price 0.2
Not a dream

good Qr Result coming out soon grab before its too late

good Qr Result coming out soon grab before its too late

good Qr Result coming out soon grab it before fly

By Kuala Lumpur Newsroom
NewsRise

KUALA LUMPUR (Oct 13) -- Malaysian healthcare equipment maker LKL International estimates to spend about 13 million ringgit ($3.13 million) to expand output as demand for healthcare products rise, its managing director said Tuesday.

The company will be able to produce 6,500 units of medical beds annually by the end of next year, Lim Kon Lian said at a news conference after annual shareholders’ meeting. Its medical bed output is currently at 5,000 units.

“We are witnessing greater demand for medical beds from hospitals and medical centers, with orders in hands of more than 750 beds, which would be delivered over the next 14 months,“ he said.

Other expansion initiatives include buying new machines at a cost of four million ringgit, and building a three storied steel structure extension and a conveyor line that will cost 9.50 million ringgit, Lim said.

In view of hefty demand, Lim expects the company will be able to maintain double-digit revenue growth through this fiscal year ending Apr. 30, 2021.

In the next three to five years, the company intends to produce own dialysis machines, Lim said.

This follows its announced plan to acquire a 60% stake in Tahmaz Meditech for 12 million ringgit.

“Tahmaz Meditech is in talks with Malaysian Armed Forces and Health Ministry on potential supply of dialysis machines to the government,“ Lim said.




- By Gho Chee Yuan; Terence.Gho@newsrise.org; 60320267363
- Edited by Abhrajit Gangopadhyay
- Send Feedback to feedback@NewsRise.org
- Copyright (c) 2020 NewsRise Financial Research & Information Services Pvt. Ltd.

good QR is coming buy before its too late

By Kuala Lumpur Newsroom
NewsRise

KUALA LUMPUR (Sep 14) -- Malaysian automated test equipment firm Aemulus Holdings is venturing into chip testing and developing components used in complementary metal oxide semiconductor, or CMOS image sensor, its chief operating officer said.

The product could also be used in the industrial sector as well as in the surveillance segment, Yeoh Chee Keong told NewsRise. The CMOS image sensor total market size is estimated to grow to $21.50 billion by 2023 from $16.1 billion this year, he said.

“We have received orders for our new product and (that) will be delivered progressively over the next 15 months,” he said, without disclosing the order value.

Aemulus is seeking to offer specialized service as part of its turnaround strategy as the company grapples with intense competition in the generic components segment.

In the last fiscal year ended Sep. 30, the company reported net loss of 3.22 million ringgit ($0.78 million) while revenue shrank 22% to 28.83 million ringgit amid sluggish economic outlook. In the latest nine-month period, net loss totaled 4.65 million ringgit on revenue of 12.11 million ringgit.

However, the company is hopeful of maintaining gross profit margin at around 60%, Yeoh said.

Aemulus aims to penetrate into radio frequency filters - a specialized product used in chips of 5G smartphones - currently dominated by two major firms, Yeoh said.

Further, the company hopes to ride on the wave of trade diversions amid ongoing Sino-U.S. economic tensions. The U.S. was considering adding China’s Semiconductor Manufacturing International Corporation to a government blacklist, according to recent media reports.

The move, the latest in the trade war between U.S. and China, could restrict suppliers from providing the company with U.S.-based technology without special permission.

Engineering activities, especially integrated circuits design works, are picking up in China following the U.S. ban., Yeoh said.

In April, the company announced a joint venture company with China’s Tangren Microtelligence Technology for semiconductor equipment and product technology transfer, he said.

“The JV is still in a very early stage and it will serve as a platform to strengthen our sales and distribution channel in China,” Yeoh added.

Shares of Aemulus, which have more-than-doubled over the past 12 months, were trading 1.6% higher at 0.63 ringgit apiece on Bursa Malaysia.




- By Gho Chee Yuan; Terence.Gho@newsrise.org;
- Edited by Jason Ng
- Send Feedback to feedback@NewsRise.org
- Copyright (c) 2020 NewsRise Financial Research & Information Services Pvt. Ltd.

Sernkou its wake up

Mrmeow U buy in what price?

https://www.thestar.com.my/business/business-news/2020/09/07/aemulus-eyes-china-opportunities

Correction overall its strong uptrend

Another same pattern with Vs buy before its too late